MONDAY, Nov. 20, 2023 (HealthDay News) — Lab-grown blood vessels are providing new insight into how damage to the tiny vessels in the brain can cause them to leak, contributing to dementia and stroke. Even better, this research has identified a drug target that could plug these leaks and potentially
WEDNESDAY, Nov. 1, 2023 (HealthDay News) — A new gene therapy for sickle cell disease was deemed safe by a U.S. Food and Drug Administration advisory panel on Tuesday, paving the way for full approval by early December. The FDA had already decided that the therapy, known as exa-cel, was effective.
MONDAY, Oct. 30, 2023 (HealthDay News) — Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition, which typically strikes Black people. The agency
TUESDAY, Sept. 12, 2023 (HealthDay News) — It’s possible that the cause of spontaneous, recurring brain hemorrhages can be passed through blood transfusion, researchers say. The likelihood of this happening is very slim, however. Still, “blood transfusions are relatively common, which makes possible negative effects an important public health issue,”
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — When astronauts travel to space, the experience depletes their red blood cells and bone, according to a new study. Fortunately, it appears their bodies can eventually replenish them after they’ve returned to Earth, thanks to fat stored in the bone marrow. “We found
FRIDAY, Aug. 18, 2023 (HealthDay News) – The 15th century prince who inspired the literary vampire Dracula may have had medical issues that caused him to cry tears of blood, according to researchers unearthing this ancient mystery. The prince, who was also a military leader, was known as Vlad III,
FRIDAY, June 30, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved a costly single-dose gene therapy for patients with severe hemophilia A, a life-threatening hereditary bleeding disorder. The treatment is not cheap: Roctavian will cost $2.9 million for a single infusion, the Associated Press reported.
THURSDAY, June 29, 2023 (HealthDay News) — Pairing exercise with a 10% weight loss can make a major health improvement in people living with obesity and prediabetes, a new study says. Building in regular exercise more than doubled sensitivity to insulin compared to just weight loss alone. This has the